COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD (MAKO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02727881
Recruitment Status : Unknown
Verified April 2017 by Ohr Pharmaceutical Inc..
Recruitment status was:  Active, not recruiting
First Posted : April 5, 2016
Last Update Posted : April 27, 2017
Information provided by (Responsible Party):
Ohr Pharmaceutical Inc.

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : December 2017